Lilly gets positive EU regulatory opinion for Omvoh for Crohn’s (LLY:NYSE)

Lilly Biotechnology Center in San Diego, California, USA. — JHVEPhoto

Eli Lilly (NYSE:LLY) has received a positive recommendation for approval from European regulators for its drug Omvoh in the treatment of Crohn’s disease.

The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion for

What's Hot

CLARITY Act Senate Vote Set for September 15

Americans Eating Alone More, Not Sharing Meals Proves Cultural Decline

Hundreds of Firms Apply for New Website to Study Russian Weapons

Lilly gets positive EU regulatory opinion for Omvoh for Crohn’s (LLY:NYSE)

Argan expects to add a handful of new projects over the next 7 to 15 months while targeting 10 to 12 simultaneous jobs (NYSE:AGX)

Boeing paid $3.1 million FAA fine over safety violations (BA:NYSE)

Everus Construction closes $295M acquisition of Epsilon Industries

CLARITY Act Senate Vote Set for September 15

Americans Eating Alone More, Not Sharing Meals Proves Cultural Decline

Hundreds of Firms Apply for New Website to Study Russian Weapons

Shopify’s COO Says Her Ideal Employee Is an ‘X-Shaped’ Person

The Business of Formula One

Weddings and divorce: the scourge of investment returns

How F1 found a secret fuel to accelerate media rights growth

Archives

Categories

What's Hot

Lilly gets positive EU regulatory opinion for Omvoh for Crohn’s (LLY:NYSE)

Related Posts

Subscribe to Updates